文 献 5）Melendez HV, Rela M, Setchell KDR, Murphy GM, Heaton ND. Bile acids analysis: A tool to assess graft function in human liver transplantation. Transpl Int 2004; 17(6): 286-92. 6）Legido‐Quigley C, McDermott L, Vilca‐Melendez H, Murphy GM, Heaton N, Lindon JC, et al. Bile UPLC‐MS fingerprinting and bile acid fluxes during human liver transplantation. Electrophoresis 2011; 32(15): 2063-70. 7）Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, et al. MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods 2015; 12(6): 523-6. 8）Tsugawa H, Kind T, Nakabayashi R, Yukihira D, Tanaka W, Cajka T, et al. Hydrogen rearrangement rules: Computational MS/MS fragmentation and structure elucidation using MS-FINDER software. Anal Chem 2016; 88(16): 7946-58.276 1）Germani G, Rodriguez-Castro K, Russo FP, Senzolo M, Zanetto A, Ferrarese A, et al. Markers of acute rejection and graft acceptance in liver transplantation. World J Gastroenterol 2015; 21(4): 1061-8. 2）El Sabagh A, Mohamed IB, Aloor FZ, Abdelwahab A, Hassan MM, Jalal PK. Current status of biomarkers and molecular diagnostic tools for rejection in liver transplantation: light at the end of the tunnel? J Clin Exp Hepatol 2023; 13(1): 139-48. 3）Frediani JK, Beyh YS, Gupta N, Westbrook AL, Cleeton R, Cordero M, et al. Metabolomics profiling in acute liver transplant rejection in a pediatric population. Sci Rep 2022; 12(1): 18663. 4）Tsai HI, Lo CJ, Lee CW, Lin JR, Lee WC, Ho HY, et al. A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation. Am J Transl Res 2021; 13(1): 372-82.
元のページ ../index.html#294